Secondary progressive multiple sclerosis and Eczema exacerbated

Summary:

Eczema exacerbated is found among people with Secondary progressive multiple sclerosis, especially for people who are male, 50-59 old.

The study analyzes which people have Eczema exacerbated with Secondary progressive multiple sclerosis. It is created by eHealthMe based on reports of 14 people who have Secondary progressive multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Secondary progressive multiple sclerosis?

Secondary progressive multiple sclerosis (a stage of ms which comes after relapsing remitting ms in many cases) is found to be associated with 137 drugs and 134 conditions by eHealthMe. Check the latest studies of Secondary progressive multiple sclerosis.

What is Eczema exacerbated?

Eczema exacerbated is found to be associated with 1,255 drugs and 534 conditions by eHealthMe. Check the latest studies of Eczema exacerbated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

14 people who have Secondary Progressive Multiple Sclerosis and Eczema Exacerbated are studied.

Would you have Eczema exacerbated when you have Secondary progressive multiple sclerosis?

Gender of people who have Secondary Progressive Multiple Sclerosis and experienced Eczema Exacerbated *:

female: 50 %
male: 50 %

Age of people who have Secondary Progressive Multiple Sclerosis and experienced Eczema Exacerbated *:

Common co-existing conditions for these people *:

Urinary Tract Infection: 1 person, 7.14%
Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 7.14%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 1 person, 7.14%
Pain: 1 person, 7.14%
Neuropathy Peripheral (surface nerve damage): 1 person, 7.14%
Muscle Spasms (muscle contraction): 1 person, 7.14%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 7.14%
Hypoaesthesia (reduced sense of touch or sensation): 1 person, 7.14%
Hypersensitivity: 1 person, 7.14%
High Blood Cholesterol: 1 person, 7.14%

Common drugs taken by these people *:

Common symptoms for these people *:

Chills (felling of cold): 3 people, 21.43%
Urinary Tract Infection: 3 people, 21.43%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 21.43%
White Blood Cell Count Decreased: 2 people, 14.29%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 2 people, 14.29%
Bradycardia (abnormally slow heart action): 2 people, 14.29%
Cough: 2 people, 14.29%
Dyspnea (difficult or laboured breathing): 2 people, 14.29%
Headache (pain in head): 2 people, 14.29%
Itching: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Eczema exacerbated?

- Check whether Eczema exacerbated is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Eczema exacerbated and Secondary progressive multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.